AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.
The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.
It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.
The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.
Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Country | United States |
IPO Date | Oct 21, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 3,771 |
CEO | Michael C. Greiner CPA |
Contact Details
Address: 5405 Windward Parkway Alpharetta, Georgia United States | |
Website | https://avanos.com |
Stock Details
Ticker Symbol | AVNS |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001606498 |
CUSIP Number | 05350V106 |
ISIN Number | US05350V1061 |
Employer ID | 46-4987888 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Michael C. Greiner CPA | Interim Chief Executive Officer, Senior Vice President & Chief Transformation Officer |
Warren J. Machan | Interim Chief Financial Officer |
David Crawford | Vice President of FP&A and Investor Relations and Treasurer |
John Joseph Hurley | Principal Accounting Officer & Controller |
John W. Cato | Vice President of Human Resources |
Kerr W. Holbrook | Senior Vice President & Chief Commercial Officer |
Lee Burnes | Senior Vice President of Global R&D, Clinical and Medical Affairs |
Michelle Scharfenberg | Senior Vice President and Chief Ethics & Compliance Officer |
Mojirade James | Senior Vice President, General Counsel & Corporate Secretary |
Scott Galovan | Vice President of Strategy & Corporate Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 13, 2025 | 8-K | Current Report |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Dec 05, 2024 | 4 | Filing |
Dec 03, 2024 | 8-K | Current Report |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 06, 2024 | 3 | Filing |